Article info
PDFThe risks of targeted therapies
Natalizumab and progressive multifocal leucoencephalopathy
- Correspondence to:
Dr J R Berger
Department of Neurology, University of Kentucky College of Medicine, Kentucky Clinic L-445, 740 S Limestone Street, Lexington, KY 40536-0284, USA; jrbneuro{at}uky.edu
Citation
Natalizumab and progressive multifocal leucoencephalopathy
Publication history
- First published October 12, 2006.
Online issue publication
April 21, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 by Annals of the Rheumatic Diseases